{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:19:20Z","timestamp":1793726360421,"version":"4.6.1"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Anesthesia"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.jclinane.2017.04.017","type":"journal-article","created":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T22:52:19Z","timestamp":1497653539000},"page":"63-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"special_numbering":"C","title":["Vasoplegic syndrome: An update on perioperative considerations"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8948-5996","authenticated-orcid":false,"given":"Henry","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longqiu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"32","key":"10.1016\/j.jclinane.2017.04.017_bb0005","first-page":"692","article-title":"Progressive vasoplegia during transfusion in post-shock vasomotor disequilibrium","volume":"60","author":"Laborit","year":"1952","journal-title":"Presse Med"},{"issue":"2","key":"10.1016\/j.jclinane.2017.04.017_bb0010","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/j.semtcvs.2010.09.007","article-title":"Vasoplegia during cardiac surgery: current concepts and management","volume":"22","author":"Fischer","year":"2010","journal-title":"Semin Thorac Cardiovasc Surg"},{"issue":"1","key":"10.1016\/j.jclinane.2017.04.017_bb0015","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/MAJ.0000000000000341","article-title":"Cardiac vasoplegia syndrome: pathophysiology, risk factors and treatment","volume":"349","author":"Omar","year":"2015","journal-title":"Am J Med Sci"},{"issue":"1","key":"10.1016\/j.jclinane.2017.04.017_bb0020","first-page":"84","article-title":"Twenty years of vasoplegic syndrome treatment in heart surgery. Methylene blue revised","volume":"30","author":"Evora","year":"2015","journal-title":"Rev Bras Cir Cardiovasc"},{"issue":"6","key":"10.1016\/j.jclinane.2017.04.017_bb0025","first-page":"574","article-title":"Three cases of splanchnic vasoplegia (Reilly syndrome) after cranial traumatism","volume":"102","author":"Escarras","year":"1965","journal-title":"Mars Med"},{"issue":"5","key":"10.1016\/j.jclinane.2017.04.017_bb0030","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1540-8191.2000.tb00470.x","article-title":"Low systemic vascular resistance after cardiopulmonary bypass: incidence, etiology, and clinical importance","volume":"15","author":"Carrel","year":"2000","journal-title":"J Card Surg"},{"key":"10.1016\/j.jclinane.2017.04.017_bb0035","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ejcts.2005.07.011","article-title":"Vasoplegic syndrome\u2014the role of methylene blue","volume":"28","author":"Shanmugam","year":"2005","journal-title":"Eur J Cardiothorac Surg"},{"issue":"1","key":"10.1016\/j.jclinane.2017.04.017_bb0040","first-page":"18","article-title":"Vasoplegic syndrome and rennin-angiotensin system antagonists","volume":"27","author":"Shear","year":"2012","journal-title":"APSF Newsl"},{"issue":"Suppl. 2","key":"10.1016\/j.jclinane.2017.04.017_bb0045","article-title":"Vasoplegic syndrome after cardiopulmonary bypass surgery \u2013 associated factors and clinical outcomes: a nested case-control study","volume":"11","author":"Iribarren","year":"2007","journal-title":"Crit. Care"},{"issue":"4","key":"10.1016\/j.jclinane.2017.04.017_bb0050","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.ejcts.2008.07.012","article-title":"Is incidence of postoperative vasoplegic syndrome different between off-pump and on pump coronary artery bypass grafting surgery?","volume":"34","author":"Sun","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"issue":"2","key":"10.1016\/j.jclinane.2017.04.017_bb0055","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0003-4975(03)01510-8","article-title":"Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery","volume":"77","author":"Levin","year":"2004","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"10.1016\/j.jclinane.2017.04.017_bb0060","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ejcts.2003.11.032","article-title":"Risk factors and outcomes for \u2018vasoplegia syndrome\u2019 following cardiac transplantation","volume":"25","author":"Byrne","year":"2004","journal-title":"Eur J Cardiothorac Surg"},{"issue":"3","key":"10.1016\/j.jclinane.2017.04.017_bb0065","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.athoracsur.2011.04.020","article-title":"Transfusion increases the risk for vasoplegia after cardiac operations","volume":"92","author":"Alfirevic","year":"2011","journal-title":"Ann Thorac Surg"},{"issue":"17","key":"10.1016\/j.jclinane.2017.04.017_bb0070","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1161\/CIRCULATIONAHA.108.814533","article-title":"Early on cardiopulmonary bypass hypotension and other factors associated with vasoplegic syndrome","volume":"120","author":"Levin","year":"2009","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jclinane.2017.04.017_bb0075","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.athoracsur.2008.07.017","article-title":"Use of methylene blue for catecholamine-refractory vasoplegia from protamine and aprotinin","volume":"87","author":"Del Duca","year":"2009","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"10.1016\/j.jclinane.2017.04.017_bb0080","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.ejcts.2009.02.006","article-title":"Vasoplegic syndrome after off-pump coronary artery bypass surgery: a rising threat","volume":"35","author":"Gomes","year":"2009","journal-title":"Eur J Cardiothorac Surg"},{"issue":"4","key":"10.1016\/j.jclinane.2017.04.017_bb0085","first-page":"482","article-title":"Cardiopulmonary bypass increases the risk of vasoplegic syndrome after coronary artery bypass grafting in patients with dialysis-dependent chronic renal failure","volume":"30","author":"Hossne Junior","year":"2015","journal-title":"Rev Bras Cir Cardiovasc"},{"issue":"2","key":"10.1016\/j.jclinane.2017.04.017_bb0090","first-page":"127","article-title":"Study of mechanism of vasoplegic syndrome for open heart surgery","volume":"82","author":"Xu","year":"2002","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"3","key":"10.1016\/j.jclinane.2017.04.017_bb0095","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1053\/j.jvca.2008.07.015","article-title":"Methylene blue for vasopressor-resistant vasoplegia syndrome during liver transplantation","volume":"24","author":"Fischer","year":"2010","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"5","key":"10.1016\/j.jclinane.2017.04.017_bb0100","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.3892\/etm.2015.2349","article-title":"Methylene blue treatment for cytokine release syndrome-associated vasoplegia following a renal transplant with rATG infusion: a case report and literature review","volume":"9","author":"Denny","year":"2015","journal-title":"Exp Ther Med"},{"issue":"11","key":"10.1016\/j.jclinane.2017.04.017_bb0105","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/pan.12742","article-title":"Methylene blue treatment for resistant shock following renal transplantation","volume":"25","author":"Hershman","year":"2015","journal-title":"Paediatr Anaesth"},{"issue":"3","key":"10.1016\/j.jclinane.2017.04.017_bb0110","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.healun.2011.10.010","article-title":"Pre-operative risk factors and clinical outcomes associated with vasoplegia in recipients of orthotopic heart transplantation in the contemporary era","volume":"31","author":"Patarroyo","year":"2012","journal-title":"J Heart Lung Transplant"},{"issue":"8","key":"10.1016\/j.jclinane.2017.04.017_bb0115","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1213\/XAA.0000000000000190","article-title":"Methylene blue for vasoplegia when on cardiopulmonary bypass during double-lung transplantation","volume":"5","author":"Carley","year":"2015","journal-title":"A A Case Rep."},{"issue":"2","key":"10.1016\/j.jclinane.2017.04.017_bb0120","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/BCR.0b013e31816677b5","article-title":"Methylene blue in the treatment of vasoplegia following severe burns","volume":"29","author":"Jaskille","year":"2008","journal-title":"J Burn Care Res"},{"issue":"2","key":"10.1016\/j.jclinane.2017.04.017_bb0125","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1097\/BCR.0000000000000134","article-title":"Methylene blue for burn-induced vasoplegia: case report and review of literature","volume":"36","author":"Church","year":"2015","journal-title":"J Burn Care Res"},{"key":"10.1016\/j.jclinane.2017.04.017_bb0130","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejphar.2015.08.030","article-title":"Matrix metalloproteinase inhibitors prevent sepsis induced refractoriness to vasoconstrictors in the cecal ligation and puncture model in rats","volume":"765","author":"de Souza","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jclinane.2017.04.017_bb0135","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1097\/CCM.0b013e318180b51d","article-title":"Role of nuclear factor-[kappa]B-dependent induction of cytokines in the regulation of vasopressin V1A-receptors during cecal ligation and puncture induced circulatory failure","volume":"36","author":"Schmidt","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jclinane.2017.04.017_bb0140","first-page":"203791","article-title":"Bezinover D use of methylene blue for treatment of severe sepsis in an immunosuppressed patient after liver transplantation","volume":"2013","author":"Ramamoorthy","year":"2013","journal-title":"Case Rep Transplant"},{"issue":"2","key":"10.1016\/j.jclinane.2017.04.017_bb0145","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20150207","article-title":"Enzymatic changes in myosin regulatory proteins may explain vasoplegia in terminally ill patients with sepsis","volume":"36","author":"Zheng","year":"2016","journal-title":"Biosci Rep"},{"issue":"5","key":"10.1016\/j.jclinane.2017.04.017_bb0150","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s00246-011-9949-0","article-title":"Clinical experience with berlin heart Excor in pediatric patients in Argentina: 1373 days of cardiac support","volume":"32","author":"Moreno","year":"2011","journal-title":"Pediatr Cardiol"},{"issue":"3","key":"10.1016\/j.jclinane.2017.04.017_bb0155","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.transproceed.2004.02.051","article-title":"Impella recover 100 microaxial left ventricular assist device: the Niguarda experience","volume":"36","author":"Garatti","year":"2004","journal-title":"Transplant Proc"},{"issue":"4","key":"10.1016\/j.jclinane.2017.04.017_bb0160","first-page":"421","article-title":"Vasoplegic syndrome after off-pump coronary artery bypass surgery: an unusual complication","volume":"31","author":"Raja","year":"2004","journal-title":"Tex Heart Inst J"},{"issue":"3","key":"10.1016\/j.jclinane.2017.04.017_bb0165","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1510\/icvts.2007.174698","article-title":"Should angiotensin converting enzyme inhibitors\/angiotensin II receptor antagonists be omitted before cardiac surgery to avoid postoperative vasodilation?","volume":"7","author":"Raja","year":"2008","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"6","key":"10.1016\/j.jclinane.2017.04.017_bb0170","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/ACO.0b013e32833eeb19","article-title":"Beta-blockers, calcium channel blockers, angiotensin converting enzyme inhibitors and angiotensin receptor blockers: should they be stopped or not before ambulatory anaesthesia?","volume":"23","author":"Smith","year":"2010","journal-title":"Curr Opin Anaesthesiol"},{"issue":"5","key":"10.1016\/j.jclinane.2017.04.017_bb0175","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.athoracsur.2004.10.038","article-title":"Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery","volume":"79","author":"Ozal","year":"2005","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jclinane.2017.04.017_bb0180","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00000539-200101000-00006","article-title":"Should the angiotensin II antagonists be discontinued before surgery?","volume":"92","author":"Bertrand","year":"2001","journal-title":"Anesth Analg"},{"issue":"1","key":"10.1016\/j.jclinane.2017.04.017_bb0185","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/ALN.0000000000001404","article-title":"Withholding versus continuing angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers before noncardiac surgery: an analysis of the vascular events in noncardiac surgery patients cohort evaluation prospective cohort","volume":"126","author":"Roshanov","year":"2017","journal-title":"Anesthesiology"},{"issue":"1","key":"10.1016\/j.jclinane.2017.04.017_bb0190","first-page":"3","article-title":"Should amiodarone be discontinued before cardiac surgery?","volume":"39","author":"Van Dyck","year":"1988","journal-title":"Acta Anaesthesiol Belg"},{"issue":"4","key":"10.1016\/j.jclinane.2017.04.017_bb0195","first-page":"205","article-title":"Acute fatal vasoplegia and asystole induced by intravenous amiodarone after cardiopulmonary bypass in a patient with preoperative cardiogenic shock","volume":"37","author":"Shieh","year":"1999","journal-title":"Acta Anaesthesiol Sin"},{"issue":"5","key":"10.1016\/j.jclinane.2017.04.017_bb0200","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/S0003-4975(01)02486-9","article-title":"Risk factors for post-cardiopulmonary bypass vasoplegia in patients with preserved left ventricular function","volume":"71","author":"Mekontso-Dessap","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jclinane.2017.04.017_bb0205","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2015-210229","article-title":"A severe case of vasoplegic shock following metformin overdose successfully treated with methylene blue as a last line therapy","volume":"2015","author":"Graham","year":"2015","journal-title":"BMJ Case Rep"},{"issue":"3","key":"10.1016\/j.jclinane.2017.04.017_bb0210","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1172\/JCI115664","article-title":"Activated macrophages depress the contractility of rabbit carotids via an l-arginine\/nitric oxide-dependent effector mechanism. Connection with amplified cytokine release","volume":"89","author":"Bernard","year":"1992","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.jclinane.2017.04.017_bb0215","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/00024382-199408000-00002","article-title":"Protein kinase C is a mediator of lipopolysaccharide induced vascular suppression in the rat aorta","volume":"2","author":"McKenna","year":"1994","journal-title":"Shock"},{"issue":"3","key":"10.1016\/j.jclinane.2017.04.017_bb0220","first-page":"301","article-title":"A role for nitric oxide in the vasoplegic syndrome","volume":"37","author":"Speziale","year":"1996","journal-title":"J Cardiovasc Surg (Torino)"},{"issue":"3","key":"10.1016\/j.jclinane.2017.04.017_bb0225","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00134-008-1279-1","article-title":"The vasopressin and copeptin response in patients with vasodilatory shock after cardiac surgery: a prospective, controlled study","volume":"35","author":"Jochberger","year":"2009","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jclinane.2017.04.017_bb0230","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1172\/JCI115820","article-title":"The ATP-sensitive K-channel mediates hypotension in endotoxemia and hypoxic lactic acidosis in dog","volume":"89","author":"Landry","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jclinane.2017.04.017_bb0235","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1161\/01.CIR.95.5.1122","article-title":"Vasopressin deficiency contributes to the vasodilation of septic shock","volume":"95","author":"Landry","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jclinane.2017.04.017_bb0240","first-page":"147","article-title":"The role of vasopressin in the maintenance of cardiovascular function during early endotoxin shock","volume":"9","author":"Brackett","year":"1983","journal-title":"Adv Shock Res"},{"key":"10.1016\/j.jclinane.2017.04.017_bb0245","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1161\/01.CIR.95.5.1108","article-title":"Role of vasopressin deficiency in the vasodilation of septic shock","volume":"95","author":"Reid","year":"1997","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.jclinane.2017.04.017_bb0250","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1053\/j.jvca.2010.09.018","article-title":"Vasopressin deficiency and vasodilatory state in end-stage liver disease","volume":"25","author":"Wagener","year":"2011","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.jclinane.2017.04.017_bb0255","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJMra002709","article-title":"The pathogenesis of vasodilatory shock","volume":"345","author":"Landry","year":"2001","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jclinane.2017.04.017_bb0260","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/01.CCM.0000206114.19707.7C","article-title":"Randomized, double-blind, placebo-controlled crossover pilot study of a potassium channel blocker in patients with septic shock","volume":"34","author":"Warrillow","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jclinane.2017.04.017_bb0265","first-page":"H688","article-title":"KATP-channel inhibition improves hemodynamics and cellular energetics in hemorrhagic hemorrhagic shock","volume":"272","author":"Salzman","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jclinane.2017.04.017_bb0270","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/00024382-200208000-00017","article-title":"New approach to treatment of shock: restitution of vasoreactivity","volume":"18","author":"Zhao","year":"2002","journal-title":"Shock"},{"key":"10.1016\/j.jclinane.2017.04.017_bb0275","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1055\/s-2007-979841","article-title":"Cardiovascular effects of conventional sulfonylureas and glimepiride","volume":"28","author":"Geisen","year":"1996","journal-title":"Horm Metab Res"},{"issue":"10 Suppl 2","key":"10.1016\/j.jclinane.2017.04.017_bb0280","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/meta.2000.17822","article-title":"Sulfonylurea sensitivity of adenosine triphosphate-sensitive potassium channels from beta cells and extrapancreatic tissues","volume":"49","author":"Gribble","year":"2000","journal-title":"Metabolism"},{"issue":"6","key":"10.1016\/j.jclinane.2017.04.017_bb0285","doi-asserted-by":"crossref","first-page":"864","DOI":"10.2310\/JIM.0b013e3181788d02","article-title":"Adenosine A2A receptor hyperexpression in patients with severe SIRS after cardiopulmonary bypass","volume":"56","author":"Kerbaul","year":"2008","journal-title":"J Invest Med"},{"issue":"3","key":"10.1016\/j.jclinane.2017.04.017_bb0290","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/01.CCM.0000201005.34203.50","article-title":"Role of endogenous adenosine as a predictive marker of Vasoplegia during cardiopulmonary bypass and postoperative severe systemic inflammatory response","volume":"34","author":"Kerbaul","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jclinane.2017.04.017_bb0295","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa067373","article-title":"Vasopressin versus norepinephrine infusion in patients with septic shock","volume":"358","author":"Russell","year":"2008","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.jclinane.2017.04.017_bb0300","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1097\/CCM.0b013e31818104b7","article-title":"Sepsis-induced vasoplegia\u2013is vasopressin V1A-receptor a new target?","volume":"36","author":"Knuefermann","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jclinane.2017.04.017_bb0305","article-title":"Etomidate mitigates lipopolysaccharide-induced CD14 and TREM-1 expression, NF-\u03baB activation, and pro-inflammatory cytokine production in rat macrophages","volume":"17","author":"Liu","year":"2015","journal-title":"Inflammation"},{"issue":"5","key":"10.1016\/j.jclinane.2017.04.017_bb0310","first-page":"619","article-title":"Vasoplegic syndrome after open heart surgery","volume":"39","author":"Gomes","year":"1998","journal-title":"J Cardiovasc Surg (Torino)"},{"issue":"3","key":"10.1016\/j.jclinane.2017.04.017_bb0315","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0022-5223(94)70355-8","article-title":"Vasoplegic syndrome: a new dilemma","volume":"107","author":"Gomes","year":"1994","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"6","key":"10.1016\/j.jclinane.2017.04.017_bb0320","doi-asserted-by":"crossref","first-page":"527","DOI":"10.4097\/kjae.2015.68.6.527","article-title":"Postreperfusion syndrome during liver transplantation","volume":"68","author":"Jeong","year":"2015","journal-title":"Korean J Anesthesiol"},{"issue":"3","key":"10.1016\/j.jclinane.2017.04.017_bb0325","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1213\/ANE.0b013e3181c99816","article-title":"Is it possible to distinguish between vasoplegic syndrome and postreperfusion syndrome during liver graft reperfusion?","volume":"110","author":"de Armas","year":"2010","journal-title":"Anesth Analg"},{"issue":"5","key":"10.1016\/j.jclinane.2017.04.017_bb0330","doi-asserted-by":"crossref","first-page":"R255","DOI":"10.1186\/cc10516","article-title":"Post cardiac surgery vasoplegia is associated with high preoperative copeptin plasma concentration","volume":"15","author":"Colson","year":"2011","journal-title":"Crit Care"},{"issue":"9","key":"10.1016\/j.jclinane.2017.04.017_bb0335","first-page":"CS114","article-title":"Vasoplegic shock during liver transplantation: is the preoperative cGMP plasma level a potential predictor of hemodynamic instability?","volume":"16","author":"Bezinover","year":"2010","journal-title":"Med Sci Monit"},{"issue":"6","key":"10.1016\/j.jclinane.2017.04.017_bb0340","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1046\/j.1540-8191.2002.01002.x","article-title":"Vasopressin therapy for vasoplegic syndrome following cardiopulmonary bypass","volume":"17","author":"Masetti","year":"2002","journal-title":"J Card Surg"},{"key":"10.1016\/j.jclinane.2017.04.017_bb0345","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1749-8090-5-17","article-title":"Perioperative infusion of low- dose of vasopressin for prevention and management of vasodilatory vasoplegic syndrome in patients undergoing coronary artery bypass grafting-a double-blind randomized study","volume":"5","author":"Papadopoulos","year":"2010","journal-title":"J Cardiothorac Surg"},{"issue":"1","key":"10.1016\/j.jclinane.2017.04.017_bb0350","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/ALN.0000000000001434","article-title":"Vasopressin versus norepinephrine in patients with Vasoplegic shock after cardiac surgery: the VANCS randomized controlled trial","volume":"126","author":"Hajjar","year":"2017","journal-title":"Anesthesiology"},{"issue":"4","key":"10.1016\/j.jclinane.2017.04.017_bb0355","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1510\/icvts.2009.209890","article-title":"A retrospective analysis of terlipressin in bolus for the management of refractory vasoplegic hypotension after cardiac surgery","volume":"9","author":"Noto","year":"2009","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.jclinane.2017.04.017_bb0360","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/S0022-5223(02)73284-4","article-title":"Methylene blue: the drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass?","volume":"125","author":"Leyh","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"10.1016\/j.jclinane.2017.04.017_bb0365","first-page":"167","article-title":"Rescue therapy with methylene blue in systemic inflammatory response syndrome after cardiac surgery","volume":"19","author":"Dagenais","year":"2003","journal-title":"Can J Cardiol"},{"issue":"4","key":"10.1016\/j.jclinane.2017.04.017_bb0370","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1067\/mtc.2001.115153","article-title":"Reversal of severe vasoplegia with single-dose methylene blue after heart transplantation","volume":"122","author":"Kofidis","year":"2001","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"10.1016\/j.jclinane.2017.04.017_bb0375","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jtcvs.2003.09.046","article-title":"Methylene blue as drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass","volume":"127","author":"Evora","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"10.1016\/j.jclinane.2017.04.017_bb0380","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1590\/S0066-782X2006001700019","article-title":"Hemodynamic and vascular endothelium function studies in healthy pigs after intravenous bolus infusion of methylene blue","volume":"87","author":"Menardi","year":"2006","journal-title":"Arq Bras Cardiol"},{"issue":"3","key":"10.1016\/j.jclinane.2017.04.017_bb0385","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1051\/ject\/200840206","article-title":"Methylene blue-induced methemoglobinemia during cardiopulmonary bypass? A case report and literature review","volume":"40","author":"McRobb","year":"2008","journal-title":"J Extra Corpor Technol"},{"issue":"3","key":"10.1016\/j.jclinane.2017.04.017_bb0390","first-page":"179","article-title":"Fatal methylene blue associated serotonin toxicity","volume":"72","author":"Top","year":"2014","journal-title":"Neth J Med"},{"issue":"4","key":"10.1016\/j.jclinane.2017.04.017_bb0395","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00045391-200307000-00009","article-title":"Methylene blue","volume":"10","author":"Clifton","year":"2003","journal-title":"Am J Ther"},{"issue":"6","key":"10.1016\/j.jclinane.2017.04.017_bb0400","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1510\/icvts.2006.134726","article-title":"Is methylene blue of benefit in treating adult patients who develop catecholamine-resistant vasoplegic syndrome during cardiac surgery?","volume":"5","author":"Leite","year":"2006","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"5","key":"10.1016\/j.jclinane.2017.04.017_bb0405","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.athoracsur.2013.08.050","article-title":"The use of high-dose hydroxocobalamin for vasoplegic syndrome","volume":"97","author":"Roderique","year":"2014","journal-title":"Ann Thorac Surg"},{"issue":"12","key":"10.1016\/j.jclinane.2017.04.017_bb0410","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1213\/XAA.0000000000000398","article-title":"Hydroxocobalamin for vasoplegic syndrome in liver transplantation: restoration of blood pressure without vasospasm","volume":"7","author":"Woehlck","year":"2016","journal-title":"A A Case Rep"},{"key":"10.1016\/j.jclinane.2017.04.017_bb0415","article-title":"Treatment of vasoplegic syndrome with intravenous hydroxocobalamin during liver transplantation: a report of 2 cases","author":"Boettcher","year":"2016","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"10","key":"10.1016\/j.jclinane.2017.04.017_bb0420","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.nut.2009.02.010","article-title":"Polyphenols in the prevention and treatment of sepsis syndromes: rationale and pre-clinical evidence","volume":"25","author":"Shapiro","year":"2009","journal-title":"Nutrition"},{"key":"10.1016\/j.jclinane.2017.04.017_bb0425","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1161\/01.HYP.27.2.228","article-title":"Indigo carmine inhibits endothelium-dependent and independent vasodilation","volume":"27","author":"Chang","year":"1996","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.jclinane.2017.04.017_bb0430","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jclinane.2009.03.009","article-title":"Like methylene blue, indigo carmine might counteract vasoplegia: hemodynamic evidence obtained with pulse contour analysis","volume":"21","author":"Archer","year":"2009","journal-title":"J Clin Anesth"},{"issue":"6","key":"10.1016\/j.jclinane.2017.04.017_bb0435","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00134-003-2138-8","article-title":"Hyperbaric oxygen therapy prevents vascular derangement during zymosan induced multiple-organ-failure syndrome","volume":"30","author":"Imperatore","year":"2004","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jclinane.2017.04.017_bb0440","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.carrev.2010.10.004","article-title":"Is vasoplegic syndrome more prevalent with open-heart procedures compared with isolated on-pump CABG surgery?","volume":"12","author":"Sun","year":"2011","journal-title":"Cardiovasc Revasc Med"}],"container-title":["Journal of Clinical Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952818016309436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952818016309436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:09:44Z","timestamp":1760605784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952818016309436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":88,"alternative-id":["S0952818016309436"],"URL":"https:\/\/doi.org\/10.1016\/j.jclinane.2017.04.017","relation":{},"ISSN":["0952-8180"],"issn-type":[{"value":"0952-8180","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vasoplegic syndrome: An update on perioperative considerations","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jclinane.2017.04.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}